At the PTAB Blog

At the PTAB Blog

Single Value Found Not Inherently Anticipated or Inherently Obvious from a Range Single Value Found Not Inherently Anticipated or Inherently Obvious from a Range

At the PTAB Blog

Finnegan Attorneys Author the Third Edition of The Practitioner’s Guide to Trials Before the Patent Trial and Appeal Board Finnegan Attorneys Author the Third Edition of The Practitioner’s Guide to Trials Before the Patent Trial and Appeal Board

At the PTAB Blog

IPR, CBM, and PGR Statistics for PTAB Final Written Decisions Through September 2022 IPR, CBM, and PGR Statistics for PTAB Final Written Decisions Through September 2022

At the PTAB Blog

PTAB Denies IPR Challenging Patent Relating to a Prenatal Vitamin PTAB Denies IPR Challenging Patent Relating to a Prenatal Vitamin

At the PTAB Blog

Product-by-Process Construction Dooms Claims Product-by-Process Construction Dooms Claims

At the PTAB Blog

Updated PTAB Guidance on Use of Applicant Admitted Prior Art in IPRs Updated PTAB Guidance on Use of Applicant Admitted Prior Art in IPRs

At the PTAB Blog

Federal Circuit PTAB Appeal Statistics for September 2022 Federal Circuit PTAB Appeal Statistics for September 2022

At the PTAB Blog

Will the Real "Another" Please Stand Up? Will the Real "Another" Please Stand Up?

At the PTAB Blog

957 Salts Too Many to "At Once Envisage"; Mylan's Attacks on Patentability Peter Out 957 Salts Too Many to "At Once Envisage"; Mylan's Attacks on Patentability Peter Out

At the PTAB Blog

No Interference Estoppel to Zynga's IPR Petition No Interference Estoppel to Zynga's IPR Petition

At the PTAB Blog

Written Description Support Pre-AIA Scuttles PGR Written Description Support Pre-AIA Scuttles PGR

At the PTAB Blog

Want to Avoid Having Your Complaint Dismissed? Plead It with Sufficient Particularity and Don’t Take Positions Contrary to What You Told PTAB Want to Avoid Having Your Complaint Dismissed? Plead It with Sufficient Particularity and Don’t Take Positions Contrary to What You Told PTAB

At the PTAB Blog

Federal Circuit PTAB Appeal Statistics for July and August 2022 Federal Circuit PTAB Appeal Statistics for July and August 2022

At the PTAB Blog

PTAB Invalidates United Therapeutics Patent Relating to the Hypertension Drug - Tyvaso® PTAB Invalidates United Therapeutics Patent Relating to the Hypertension Drug - Tyvaso®

At the PTAB Blog

USPTO Director Initiates Sua Sponte Review to Address Timing of Finitiv Factor 4 Stipulation USPTO Director Initiates Sua Sponte Review to Address Timing of Finitiv Factor 4 Stipulation

At the PTAB Blog

Tie Your Evidence of a Specific Sample Tested to What Was Allegedly in the Prior Art Tie Your Evidence of a Specific Sample Tested to What Was Allegedly in the Prior Art

At the PTAB Blog

USPTO Refusal to Accept Requests for Director Review of Institution Decisions Not an Appointments Clause Violation USPTO Refusal to Accept Requests for Director Review of Institution Decisions Not an Appointments Clause Violation

At the PTAB Blog

Petitioner Estoppel Applies: Giving Effect to “Reasonably Could Have Raised” Petitioner Estoppel Applies: Giving Effect to “Reasonably Could Have Raised”

At the PTAB Blog

Will SawStop “Nick” OTDP? Will SawStop “Nick” OTDP?

At the PTAB Blog

A Stitch in Time Saves Nine, Unless It Doesn’t A Stitch in Time Saves Nine, Unless It Doesn’t

At the PTAB Blog

When “Good Enough” Is Good Enough for Finding Obviousness When “Good Enough” Is Good Enough for Finding Obviousness

At the PTAB Blog

Federal Circuit PTAB Appeal Statistics Through June 30, 2022 Federal Circuit PTAB Appeal Statistics Through June 30, 2022

At the PTAB Blog

Past Its Peak: Freedom to Operate, Inc. Fails to Persuade PTAB to Institute Two Post-Grant Reviews for Patents Covering Psilocybin Past Its Peak: Freedom to Operate, Inc. Fails to Persuade PTAB to Institute Two Post-Grant Reviews for Patents Covering Psilocybin

At the PTAB Blog

Federal Circuit PTAB Appeal Statistics Through May 31, 2022 Federal Circuit PTAB Appeal Statistics Through May 31, 2022

At the PTAB Blog

Goodbye ARC and Hello CJP: USPTO Creates Interim Process for PTAB Decision Circulation and Review Goodbye ARC and Hello CJP: USPTO Creates Interim Process for PTAB Decision Circulation and Review